OvaScience Company Profile (NASDAQ:OVAS)

Analyst Ratings

Consensus Ratings for OvaScience (NASDAQ:OVAS) (?)
Ratings Breakdown: 1 Sell Rating(s), 3 Hold Rating(s), 2 Buy Rating(s)
Consensus Rating:Hold (Score: 2.17)
Consensus Price Target: $12.37 (141.05% upside)

Analysts' Ratings History for OvaScience (NASDAQ:OVAS)
Show:
DateFirmActionRatingPrice TargetActions
7/12/2016Credit Suisse Group AGReiterated RatingSellView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/8/2016Leerink SwannReiterated RatingHold$6.00 -> $7.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/25/2016Oppenheimer Holdings Inc.Reiterated RatingHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/21/2016S&P Equity ResearchLower Price Target$10.82 -> $8.83View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/17/2016HC WainwrightReiterated RatingBuy$15.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/2/2015WedbushLower Price TargetOutperform$46.00 -> $15.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/29/2015JMP SecuritiesDowngradeOutperform -> Market PerformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/29/2015JPMorgan Chase & Co.Initiated CoverageNeutral$40.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/24/2014 forward)

Earnings

Earnings History for OvaScience (NASDAQ:OVAS)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
8/8/2016        
5/5/2016Q116($0.72)($0.80)$0.14 million$0.15 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/25/2016Q315($0.71)($0.76)$0.27 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/5/2015Q3($0.68)($0.66)$0.17 million$0.08 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/10/2015Q215($0.64)($0.64)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/11/2015($0.65)($0.65)$0.40 million$0.02 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/16/2015Q414($0.59)($0.79)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/10/2014Q314($0.44)($0.54)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/7/2014Q214($0.45)($0.42)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/8/2014($0.46)($0.41)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/27/2014Q413($0.39)($0.64)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/13/2013Q313($0.35)($0.40)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/13/2013Q213($0.28)($0.36)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for OvaScience (NASDAQ:OVAS)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q2 20161($0.81)($0.81)($0.81)
Q3 20161($0.81)($0.81)($0.81)
Q4 20161($0.70)($0.70)($0.70)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for OvaScience (NASDAQ:OVAS)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for OvaScience (NASDAQ:OVAS)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
6/1/2016Michelle DippCEOBuy425,000$7.00$2,975,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/18/2016Michelle DippCEOBuy20,000$7.86$157,200.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/17/2016Michelle DippCEOBuy40,000$7.63$305,200.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/13/2016Richard AldrichDirectorBuy36,095$6.94$250,499.30View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/11/2016Richard AldrichDirectorBuy20,000$7.64$152,800.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/10/2016Michelle DippCEOBuy19,900$7.72$153,628.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/10/2016Paul W.D. ChapmanCOOBuy3,100$7.37$22,847.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/24/2016Michelle DippCEOBuy59,800$9.49$567,502.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/22/2016Michelle DippCEOBuy59,800$10.44$624,312.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/18/2016Michelle DippCEOBuy59,700$8.26$493,122.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/16/2016Michelle DippCEOBuy59,029$7.90$466,329.10View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/14/2016Michelle DippCEOBuy162,732$7.60$1,236,763.20View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/5/2015Jeffrey E YoungCFOBuy3,450$10.70$36,915.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/5/2015Marc D KozinDirectorBuy4,800$10.79$51,792.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/9/2015Mary FisherDirectorBuy6,100$16.49$100,589.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/8/2015Marc D KozinDirectorBuy3,000$17.60$52,800.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/8/2015Marc D KozinDirectorBuy3,000$28.45$85,350.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/2/2015Michelle DippCEOBuy1,000$32.49$32,490.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/13/2015Thomas MalleyDirectorBuy35,000$50.00$1,750,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/7/2014Richard AldrichDirectorBuy2,000$9.49$18,980.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/30/2014Richard AldrichDirectorBuy2,000$9.16$18,320.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/23/2014Richard AldrichDirectorBuy2,000$8.81$17,620.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/16/2014Richard AldrichDirectorBuy2,000$8.52$17,040.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/9/2014Richard AldrichDirectorBuy2,000$7.59$15,180.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/3/2014Harald F StockDirectorBuy1,063$7.01$7,451.63View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/2/2014Richard AldrichDirectorBuy2,000$7.29$14,580.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/27/2014Richard AldrichDirectorBuy2,000$7.50$15,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/20/2014Harald F StockDirectorBuy1,050$7.13$7,486.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/19/2014Richard AldrichDirectorBuy2,000$7.33$14,660.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/7/2014Fund L.P. LongwoodMajor ShareholderBuy100,000$10.00$1,000,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/12/2013Arthur TzianabosInsiderBuy1,000$10.32$10,320.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/12/2013Harald F StockDirectorBuy4,500$10.64$47,880.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/11/2013Christopher A BleckInsiderBuy2,000$11.15$22,300.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/11/2013Richard AldrichDirectorBuy4,850$10.54$51,119.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for OvaScience (NASDAQ:OVAS)
DateHeadline
07/23/16 09:37 AMOvascience Inc. (NASDAQ:OVAS): Sell-Side Ratings and Company Earnings Glance - Engelwood Daily
07/20/16 06:29 PMEquity Roundup: Stock Performance Focus on Ovascience Inc. (NASDAQ:OVAS) - Press Telegraph
07/20/16 06:29 PMCould OvaScience Inc Rise Even More? The Stock Had Another Big Increase Today - Consumer Eagle
07/19/16 05:51 PMHeightened Volatility Spotted on Shares of: OvaScience, Inc. (NASDAQ:OVAS) - Engelwood Daily
07/19/16 05:51 PMIs $15 Price Target Attainable For Ovascience Inc. (NASDAQ:OVAS)? - Investor Newswire
07/19/16 05:51 PMOvaScience Inc. (OVAS) Jumps 5.14% on July 18 - Equities.com
07/19/16 06:41 AMEarnings Focus and Crowd Sourced Sentiment Review for Ovascience Inc. (NASDAQ:OVAS) - TGP
07/18/16 11:06 AMWere Analysts Bullish OvaScience Inc (NASDAQ:OVAS) This Week? - Consumer Eagle
07/18/16 11:06 AMShares Moving Down on the Week: OvaScience, Inc. (NASDAQ:OVAS) - Engelwood Daily
07/18/16 11:06 AMNext Weeks Broker Price Targets For Ovascience Inc. (OVAS) - Fiscal Standard
07/15/16 10:45 AMOvascience Inc. (NASDAQ:OVAS) Earnings Concentration and Analyst Target Watch - Engelwood Daily
07/15/16 10:45 AMWhat's Ahead for OvaScience Inc After Today's Huge Decline? - Consumer Eagle
07/14/16 06:00 PMEye on Stock Volatility for: OvaScience, Inc. (NASDAQ:OVAS) - Engelwood Daily
07/14/16 06:00 PMAnalyst Target and Average Rating Watch: Ovascience Inc. (NASDAQ:OVAS) - Press Telegraph
07/14/16 06:00 PMOvaScience Inc Realized Volatility Hits Extreme Level - CML News
07/13/16 06:02 PMShare Volatility Watch for: OvaScience, Inc. (NASDAQ:OVAS) - Engelwood Daily
07/13/16 08:38 AMStrong Sell Calls For Ovascience Inc. (NASDAQ:OVAS) At 0 - Investor Newswire
07/13/16 08:38 AMOption Market: OvaScience Inc Risk Hits An Extreme High - CML News
07/10/16 09:50 AMDo Institutional Investors Hate Ovascience Inc (NASDAQ:OVAS)? - Engelwood Daily
07/09/16 08:53 AMAre Analysts Bullish OvaScience Inc (NASDAQ:OVAS) After Last Week? - Engelwood Daily
07/08/16 08:37 AMOvaScience, Inc. Stock Momentum Hits Weakness - CML News
07/07/16 08:36 AMIn- Vitro Fertilization (IVF) Market to Reach $5.66 billion with 20.9% CAGR to 2022
07/06/16 05:54 PMShare Performance Recap for: OvaScience, Inc. (NASDAQ:OVAS) - Press Telegraph
07/06/16 05:54 PMOvascience Inc. (NASDAQ:OVAS) Expected to Reach Highs Of $15 - Investor Newswire
07/06/16 05:54 PMOvaScience Inc. (OVAS) Drops 5.73% on July 05 - Equities.com
07/02/16 08:28 AMTracking Stock Volatility for: OvaScience, Inc. (NASDAQ:OVAS) - Engelwood Daily
07/01/16 08:27 AMRecently Issued Stock Ratings For Ovascience Inc. (OVAS) - Fiscal Standard
07/01/16 07:19 AMOVASCIENCE, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits -
07/01/16 06:10 AM7:10 am OvaScience announces Dr. Harald Stock has officially succeeded co-founder Michelle Dipp as CEO, completing the planned leadership transition from CEO-elect -
07/01/16 06:00 AMHarald Stock, Ph.D. Commences Role as President and Chief Executive Officer of OvaScience - [Business Wire] - OvaScienceSM , a global fertility company focused on the discovery, development and commercialization of new treatment options, today announced that Harald F. Stock, Ph.D., has officially assumed the role of President and Chief Executive Officer, completing a planned leadership transition from Chief Executive Officer-Elect.
06/29/16 05:36 PMCan OvaScience Inc's Tomorrow Be Different? The Stock Increases Again - Engelwood Daily
06/29/16 05:36 PMOvaScience Inc. (OVAS) Jumps 11.97% on June 28 - Equities.com
06/28/16 05:38 PMCheck on Share Volatility: OvaScience, Inc. (NASDAQ:OVAS) - Engelwood Daily
06/28/16 05:38 PMOvaScience Inc (NASDAQ:OVAS)'s Company Shares Decreased 31.01% After High Volatility - Engelwood Daily
06/28/16 10:33 AMWhat Investors are Making of These Biotech Stocks? - ChemoCentryx, Alder Biopharma, Neothetics, and OvaScience
06/26/16 10:13 AMOvaScience : El Pasoan a star in biotech industry
06/25/16 05:11 PMHow Many OvaScience Inc (NASDAQ:OVAS)'s Analysts Are Bearish? - Engelwood Daily
06/24/16 08:17 AMOvascience Inc. (NASDAQ:OVAS) Earnings Glance and Target Price Review - Engelwood Daily
06/23/16 06:15 PMThe 2016 Report on In- Vitro Fertilization (IVF) World Market Segmentation and 10 Major Manufacturers Analysis
06/23/16 08:21 AMOvaScience, Inc. (NasdaqGM:OVAS) Stock Momentum Hits EXTREME Weakness - CML News
06/22/16 05:35 PMStrong Buy Calls Count For Ovascience Inc. (NASDAQ:OVAS) At 2 - Investor Newswire
06/22/16 05:35 PMOvaScience, Inc. (NASDAQ:OVAS) headlining after earnings - iStreetWire
06/20/16 07:18 AMOvascience Inc. (OVAS) Analyst Price Targets For The Coming Week - Fiscal Standard
06/17/16 07:00 AMOvaScience to Present at the JMP Securities Life Sciences Conference - [Business Wire] - OvaScienceSM , a global fertility company focused on the discovery, development and commercialization of new treatment options, announced today that Company management will present at the JMP Securities Life Sciences Conference on Tuesday, June 21, 2016 at 11:30 am ET at the St.
06/16/16 05:56 PMLearn details of the World in vitro fertilization devices & consumables market to grow at a CAGR of 19.7%
06/13/16 08:40 AMEarnings Trend per share for Investors: Seattle Genetics, Inc. (NASDAQ:SGEN), OvaScience, Inc. (NASDAQ:OVAS) - Beacon Chronicle
06/13/16 08:40 AMLast Traded Price Fluctuations: Quest Diagnostics Incorporated (NYSE:DGX) , Ovascience Inc. (NASDAQ:OVAS) - Street Updates
06/10/16 05:59 PMOvaScience Inc. (OVAS) Drops 9.33% on June 09 - Equities.com
06/10/16 08:40 AMTwo Stocks within Traders Observation: Skyline Medical Inc. (NASDAQ:SKLN) , Ovascience Inc. (NASDAQ:OVAS) - Street Updates
06/08/16 06:08 PMOVASCIENCE INC. (NASDAQ:OVAS) Financial Condition Compared to S&P 500 - CML News

Social

About OvaScience

OvaScience logoOvaScience, Inc. is a global fertility company. The Company is focused on the discovery, development and commercialization of fertility treatment options for women. The Company's portfolio of fertility treatment options uses its technology, including methods to identify and isolate Egg precursor (EggPC) cells from a patient's own ovarian tissue. The Company's AUGMENT treatment is designed to improve egg health by supplementing a mitochondrial deficiency. With the AUGMENT treatment, energy-producing mitochondria from a patient's own EggPC cells are added to the patient's mature eggs during the in vitro fertilization process to supplement the existing mitochondria. Its OvaPrime treatment is a fertility treatment designed to replenish a woman's ovary by increasing her egg reserve using her own EggPC cells. Its OvaTure treatment is a fertility treatment that seeks to create mature fertilizable eggs in vitro from a woman's own EggPC cells without the need for hormone hyperstimulation.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: OVAS
  • CUSIP:
Key Metrics:
  • Previous Close: $5.13
  • 50 Day Moving Average: $5.57
  • 200 Day Moving Average: $7.27
  • P/E Ratio: N/A
  • P/E Growth: 0.00
  • Market Cap: $140.19M
  • Beta: 4.19
  • Current Year EPS Consensus Estimate: $-3.2 EPS
  • Next Year EPS Consensus Estimate: $-2.58 EPS
Additional Links:
OvaScience (NASDAQ:OVAS) Chart for Sunday, July, 24, 2016